You are here: Industry Insights > mRNA

News List

AHA News: Pfizer, Moderna Officials Review COVID-19 Vaccine Successes, Discuss Future for mRNA Tech Drugs
November 17, 2021
Leaders from the two companies responsible for America's most-used COVID-19 vaccines looked back Saturday at how they were able to develop the lifesaving shots so quickly...
Astellas and Pantherna Enter into Technology Evaluation Agreement for Research of mRNA-based Regenerative Medicine FirstWordPharma
November 15, 2021
Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Pantherna Therapeutics GmbH (CEO: Klaus Giese, Ph.D., "Pantherna") today announced that the companies...
BioNet and BIA Separations Collaborate on mRNA Manufacturing Process ContractPharma
November 03, 2021
BioNet, a biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a biochromatography development and manufacturing company...
Hanmi Science Consortium Drives Ambitious Project for Worldwide Vaccine Equity prnasia
October 29, 2021
Hanmi Science doesn't just want the world to know they are committed to vaccine equity, they want to prove it. Mr. Lim, CEO of Hanmi Science, echoes the concerns of Mr. Bill Gates, co-founder of the Bill & Melinda Gates Foundation.
CPhI Monthly Podcast: The opportunities and challenges of providing fill and finish services for mRNA platforms cphi-online
August 23, 2021
mRNA (Messenger ribonucleuc acid) technology has been thrust into the limelight in recent months, with the platform proving to be the springboard for two approved vaccines against the SARS-CoV-2 virus.
Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improved Immune Response and Protection in Preclinical Study drugs
August 20, 2021
CureVac N.V. (Nasdaq: CVAC), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), and GSK today announced the publication of preclinical data investigating immune responses.
A protein-based COVID-19 vaccine that mimics the shape of the virus worldpharmanews
August 13, 2021
Even as several safe and effective COVID-19 vaccines are being administered to people worldwide, scientists are still hard at work developing different vaccine strategies that could provide even stronger or longer-lasting immunity against SARS-CoV-2 ...
NIH launches study of third COVID-19 vaccine dose in kidney transplant recipients expresspharma
August 12, 2021
A pilot study has begun to assess the antibody response to a third dose of an authorised COVID-19 mRNA vaccine in kidney transplant recipients who did not respond to two doses of the Moderna or Pfizer-BioNTech COVID-19 vaccine.
Aldevron, Ginkgo Bioworks Partner on mRNA Vax Mfg. Breakthrough contractpharma
August 12, 2021
Achieved improvements in manufacturing yield of vaccinia capping enzyme (VCE), a component often required to produce mRNA therapies and vaccines.
From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice expresspharma
August 09, 2021
Arun Kedia, Managing Director, VAV Life Sciences, elaborates how NDDS have proved to be beneficial with applications across various medical therapies ranging from HIV to cancer to COVID-19 treatment.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page